Visión generalGráficoNoticiasTraderScreen

RBI Aktienanleihe FACC 26.03.2025/  AT0000A37NX2  /

Stuttgart
08/11/2024  9:16:05 Diferencia-0.790 Bid16:37:18 Ask16:37:18 Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
114.070EUR -0.69% 114.340
Volumen de oferta: 50,000		 114.590
Tamaño/ Volumen/ Formato de Ask: 50,000		 FACC AG INH.AKT. 5.80 EUR 26/03/2025 Call
GlobeNewswire 26/08 Milestone® Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024
GlobeNewswire 14/08 19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. Georg...
GlobeNewswire 13/08 Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Expansion of the Phase 2b MOVE-IT Study of ...
GlobeNewswire 12/08 Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 08/08 Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and ...
GlobeNewswire 31/07 BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation
GlobeNewswire 28/07 Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alz...
GlobeNewswire 18/07 HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in ...
GlobeNewswire 17/07 Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mil...
GlobeNewswire 10/07 Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Desig...
GlobeNewswire 09/07 New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference
GlobeNewswire 08/07 Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weigh...
GlobeNewswire 17/06 Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Init...
GlobeNewswire 12/06 Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspect...
GlobeNewswire 10/06 Clinical ink Appoints Dr. Nicholas Alp, MD PhD FACC as Chief Medical Officer
GlobeNewswire 05/06 Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer
GlobeNewswire 04/06 Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Le...
GlobeNewswire 17/05 Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine
GlobeNewswire 17/05 Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biol...
GlobeNewswire 16/05 CVRx Announces Key Senior Leadership Team Hires
GlobeNewswire 15/05 Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
GlobeNewswire 15/05 HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REV...
GlobeNewswire 07/05 Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presenta...
GlobeNewswire 07/05 Rugby Provides Exploration Update on its Gold-Silver Projects in  Santa Cruz Province, Argentina
GlobeNewswire 02/05 Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stan...